CHICAGO (AP) — For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy.
via Health News Headlines - Yahoo News http://ift.tt/1wGv20f
via Health News Headlines - Yahoo News http://ift.tt/1wGv20f
No comments:
Post a Comment